The Nbryo technology platform is being developed to improve productivity and environmental outcomes in three ways:
The Nbryo platform will deliver accurate identification of desirable traits and an increased selection intensity, providing benefits across the entire value chain.
Pictured below: An example case study of a New Zealand large mixed dairy and beef operation detailing value chain benefits.
The underlying concept on which the Nbryo platform is based is to provide low cost, accessible embryo transfer on a large scale. The concept arose from learnings following over 15 years of commercial embryo transfer and genomics research and development conducted at Nindooinbah – an elite beef breeding property in regional Queensland, Australia. The company’s founders created Nbryo Pty Ltd to realise that underlying concept.
Research to develop the Nbryo platform to date has been funded by Meat & Livestock Australia (MLA), Bill & Melinda Gates Foundation and Nbryo Pty Ltd. Additionally, Nbryo has attracted significant equity investment to develop its commercialisation capability.
Nbryo’s product development road map encompasses work in a wide variety of scientific disciplines including biology, genomics, engineering, biosensors as well as data science. The strength of the platform comes from the integration of outcomes from all of these disciplines.
Providing a robust governance framework for our research program, the Nbryo Scientific Advisory Committee (SAC) offers decades of global industry experience across biotechnology, agriculture and animal health.
Pictured right: Committee members, Nbryo team and guest following recent SAC meeting.